Cargando…

Predictive Modeling of Thoracic Radiotherapy Toxicity and the Potential Role of Serum Alpha-2-Macroglobulin

Background: To investigate the impact of alpha-2-macroglobulin (A2M), a suspected intrinsic radioprotectant, on radiation pneumonitis and esophagitis using multifactorial predictive models. Materials and Methods: Baseline A2M levels were obtained for 258 patients prior to thoracic radiotherapy (RT)....

Descripción completa

Detalles Bibliográficos
Autores principales: von Reibnitz, Donata, Yorke, Ellen D., Oh, Jung Hun, Apte, Aditya P., Yang, Jie, Pham, Hai, Thor, Maria, Wu, Abraham J., Fleisher, Martin, Gelb, Emily, Deasy, Joseph O., Rimner, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7423838/
https://www.ncbi.nlm.nih.gov/pubmed/32850450
http://dx.doi.org/10.3389/fonc.2020.01395
_version_ 1783570205831593984
author von Reibnitz, Donata
Yorke, Ellen D.
Oh, Jung Hun
Apte, Aditya P.
Yang, Jie
Pham, Hai
Thor, Maria
Wu, Abraham J.
Fleisher, Martin
Gelb, Emily
Deasy, Joseph O.
Rimner, Andreas
author_facet von Reibnitz, Donata
Yorke, Ellen D.
Oh, Jung Hun
Apte, Aditya P.
Yang, Jie
Pham, Hai
Thor, Maria
Wu, Abraham J.
Fleisher, Martin
Gelb, Emily
Deasy, Joseph O.
Rimner, Andreas
author_sort von Reibnitz, Donata
collection PubMed
description Background: To investigate the impact of alpha-2-macroglobulin (A2M), a suspected intrinsic radioprotectant, on radiation pneumonitis and esophagitis using multifactorial predictive models. Materials and Methods: Baseline A2M levels were obtained for 258 patients prior to thoracic radiotherapy (RT). Dose-volume characteristics were extracted from treatment plans. Spearman's correlation (Rs) test was used to correlate clinical and dosimetric variables with toxicities. Toxicity prediction models were built using least absolute shrinkage and selection operator (LASSO) logistic regression on 1,000 bootstrapped datasets. Results: Grade ≥2 esophagitis and pneumonitis developed in 61 (23.6%) and 36 (14.0%) patients, respectively. The median A2M level was 191 mg/dL (range: 94–511). Never/former/current smoker status was 47 (18.2%)/179 (69.4%)/32 (12.4%). We found a significant negative univariate correlation between baseline A2M levels and esophagitis (Rs = −0.18/p = 0.003) and between A2M and smoking status (Rs = 0.13/p = 0.04). Further significant parameters for grade ≥2 esophagitis included age (Rs = −0.32/p < 0.0001), chemotherapy use (Rs = 0.56/p < 0.0001), dose per fraction (Rs = −0.57/p < 0.0001), total dose (Rs = 0.35/p < 0.0001), and several other dosimetric variables with Rs > 0.5 (p < 0.0001). The only significant non-dosimetric parameter for grade ≥2 pneumonitis was sex (Rs = −0.32/p = 0.037) with higher risk for women. For pneumonitis D15 (lung) (Rs = 0.19/p = 0.006) and D45 (heart) (Rs = 0.16/p = 0.016) had the highest correlation. LASSO models applied on the validation data were statistically significant and resulted in areas under the receiver operating characteristic curve of 0.84 (esophagitis) and 0.78 (pneumonitis). Multivariate predictive models did not require A2M to reach maximum predictive power. Conclusion: This is the first study showing a likely association of higher baseline A2M values with lower risk of radiation esophagitis and with smoking status. However, the baseline A2M level was not a significant risk factor for radiation pneumonitis.
format Online
Article
Text
id pubmed-7423838
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-74238382020-08-25 Predictive Modeling of Thoracic Radiotherapy Toxicity and the Potential Role of Serum Alpha-2-Macroglobulin von Reibnitz, Donata Yorke, Ellen D. Oh, Jung Hun Apte, Aditya P. Yang, Jie Pham, Hai Thor, Maria Wu, Abraham J. Fleisher, Martin Gelb, Emily Deasy, Joseph O. Rimner, Andreas Front Oncol Oncology Background: To investigate the impact of alpha-2-macroglobulin (A2M), a suspected intrinsic radioprotectant, on radiation pneumonitis and esophagitis using multifactorial predictive models. Materials and Methods: Baseline A2M levels were obtained for 258 patients prior to thoracic radiotherapy (RT). Dose-volume characteristics were extracted from treatment plans. Spearman's correlation (Rs) test was used to correlate clinical and dosimetric variables with toxicities. Toxicity prediction models were built using least absolute shrinkage and selection operator (LASSO) logistic regression on 1,000 bootstrapped datasets. Results: Grade ≥2 esophagitis and pneumonitis developed in 61 (23.6%) and 36 (14.0%) patients, respectively. The median A2M level was 191 mg/dL (range: 94–511). Never/former/current smoker status was 47 (18.2%)/179 (69.4%)/32 (12.4%). We found a significant negative univariate correlation between baseline A2M levels and esophagitis (Rs = −0.18/p = 0.003) and between A2M and smoking status (Rs = 0.13/p = 0.04). Further significant parameters for grade ≥2 esophagitis included age (Rs = −0.32/p < 0.0001), chemotherapy use (Rs = 0.56/p < 0.0001), dose per fraction (Rs = −0.57/p < 0.0001), total dose (Rs = 0.35/p < 0.0001), and several other dosimetric variables with Rs > 0.5 (p < 0.0001). The only significant non-dosimetric parameter for grade ≥2 pneumonitis was sex (Rs = −0.32/p = 0.037) with higher risk for women. For pneumonitis D15 (lung) (Rs = 0.19/p = 0.006) and D45 (heart) (Rs = 0.16/p = 0.016) had the highest correlation. LASSO models applied on the validation data were statistically significant and resulted in areas under the receiver operating characteristic curve of 0.84 (esophagitis) and 0.78 (pneumonitis). Multivariate predictive models did not require A2M to reach maximum predictive power. Conclusion: This is the first study showing a likely association of higher baseline A2M values with lower risk of radiation esophagitis and with smoking status. However, the baseline A2M level was not a significant risk factor for radiation pneumonitis. Frontiers Media S.A. 2020-08-06 /pmc/articles/PMC7423838/ /pubmed/32850450 http://dx.doi.org/10.3389/fonc.2020.01395 Text en Copyright © 2020 von Reibnitz, Yorke, Oh, Apte, Yang, Pham, Thor, Wu, Fleisher, Gelb, Deasy and Rimner. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
von Reibnitz, Donata
Yorke, Ellen D.
Oh, Jung Hun
Apte, Aditya P.
Yang, Jie
Pham, Hai
Thor, Maria
Wu, Abraham J.
Fleisher, Martin
Gelb, Emily
Deasy, Joseph O.
Rimner, Andreas
Predictive Modeling of Thoracic Radiotherapy Toxicity and the Potential Role of Serum Alpha-2-Macroglobulin
title Predictive Modeling of Thoracic Radiotherapy Toxicity and the Potential Role of Serum Alpha-2-Macroglobulin
title_full Predictive Modeling of Thoracic Radiotherapy Toxicity and the Potential Role of Serum Alpha-2-Macroglobulin
title_fullStr Predictive Modeling of Thoracic Radiotherapy Toxicity and the Potential Role of Serum Alpha-2-Macroglobulin
title_full_unstemmed Predictive Modeling of Thoracic Radiotherapy Toxicity and the Potential Role of Serum Alpha-2-Macroglobulin
title_short Predictive Modeling of Thoracic Radiotherapy Toxicity and the Potential Role of Serum Alpha-2-Macroglobulin
title_sort predictive modeling of thoracic radiotherapy toxicity and the potential role of serum alpha-2-macroglobulin
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7423838/
https://www.ncbi.nlm.nih.gov/pubmed/32850450
http://dx.doi.org/10.3389/fonc.2020.01395
work_keys_str_mv AT vonreibnitzdonata predictivemodelingofthoracicradiotherapytoxicityandthepotentialroleofserumalpha2macroglobulin
AT yorkeellend predictivemodelingofthoracicradiotherapytoxicityandthepotentialroleofserumalpha2macroglobulin
AT ohjunghun predictivemodelingofthoracicradiotherapytoxicityandthepotentialroleofserumalpha2macroglobulin
AT apteadityap predictivemodelingofthoracicradiotherapytoxicityandthepotentialroleofserumalpha2macroglobulin
AT yangjie predictivemodelingofthoracicradiotherapytoxicityandthepotentialroleofserumalpha2macroglobulin
AT phamhai predictivemodelingofthoracicradiotherapytoxicityandthepotentialroleofserumalpha2macroglobulin
AT thormaria predictivemodelingofthoracicradiotherapytoxicityandthepotentialroleofserumalpha2macroglobulin
AT wuabrahamj predictivemodelingofthoracicradiotherapytoxicityandthepotentialroleofserumalpha2macroglobulin
AT fleishermartin predictivemodelingofthoracicradiotherapytoxicityandthepotentialroleofserumalpha2macroglobulin
AT gelbemily predictivemodelingofthoracicradiotherapytoxicityandthepotentialroleofserumalpha2macroglobulin
AT deasyjosepho predictivemodelingofthoracicradiotherapytoxicityandthepotentialroleofserumalpha2macroglobulin
AT rimnerandreas predictivemodelingofthoracicradiotherapytoxicityandthepotentialroleofserumalpha2macroglobulin